Biontech free cash flow

Biontech (BNTX) reported $317M in free cash flow for fiscal 2025, +$403M from the year before.

Free cash flow — Free cash flow is operating cash flow minus capital expenditure: what is left once the company has paid to maintain and expand its asset base. We calculate it from two lines in the same filing, and a company is only ranked here if it reported both.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026

Figures are reported under IFRS in EUR and converted to US dollars at ECB reference rates — fiscal 2025 average 0.885 EUR/$ for income items, year-end 0.851 EUR/$ for balance-sheet items.

Calculated from two reported figures, so it has no single filing of its own.

{{cite web |title=Biontech free cash flow |url=https://companiesranked.com/en/company/biontech/free-cash-flow |website=CompaniesRanked |date=2026-09-25 |language=en}}

CompaniesRanked. (September 25, 2026). Biontech free cash flow. CompaniesRanked. https://companiesranked.com/en/company/biontech/free-cash-flow

@misc{companiesranked-en-company-biontech-free-cash-flow-2026,
  author       = {{CompaniesRanked}},
  title        = {{Biontech free cash flow}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/biontech/free-cash-flow}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

← Biontech overview